MG
PACB icon

Michael Gelband’s Pacific Biosciences PACB Stock Holding History

Michael Gelband’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50,000
Closed -$1.3M – 2475
2020
Q4 		$1.3M Sell
50,000
-207,000
-81% -$3.52M 0.01% 724
2020
Q3 		$2.54M Buy
+257,000
New +$1.48M 0.05% 332

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Michael Gelband's PACB Position: Q2 2026 in Review

Michael Gelband opened a new position in Pacific Biosciences (PACB) in Q2 2026: 17,004 shares worth $28.6K. The stake represents ﹤0.01% of the portfolio and ranks #1490 among its holdings. This is a return to the name: Michael Gelband previously reported a position in PACB as recently as Q2 2025.

Michael Gelband first reported a position in PACB in Q3 2019 and has held it in 7 quarters since. The position peaked at $2.76M in Q4 2020. 222 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Michael Gelband held 17,004 shares of Pacific Biosciences worth $28.6K as of Q2 2026.
  • Pacific Biosciences was a new Michael Gelband position in Q2 2026.
  • Pacific Biosciences made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1490 holding.
  • Michael Gelband first reported a position in Pacific Biosciences in Q3 2019 and has held it in 7 quarters since.
  • Michael Gelband's Pacific Biosciences position peaked at $2.76M in Q4 2020.
  • 222 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.